Adapsyn Bioscience enters into strategic collaboration with Evotec
ORIGINAL PRESS RELEASE, PR Newswire, September 21, 2022 Adapsyn Bioscience Inc., a chemical bioinformatics company
ORIGINAL PRESS RELEASE, PR Newswire, September 21, 2022 Adapsyn Bioscience Inc., a chemical bioinformatics company
$50,000 Awarded as 300 Members of the Innovation Community Celebrate HAMILTON, ON – September 29,
Original Press Release, Yahoo Finance, September 21, 2022 NORTH BRUNSWICK, N.J., Sept. 21, 2022 —
Take a listen to our latest podcast as Rachel Bartholomew, CEO and Founder of Hyivy Health shares her medical device commercialization journey.
Swati Matta, CEO & Founder of Koble, shares her startup journey and POV on the challenges of being a woman in the tech industry.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
ORIGINAL PRESS RELEASE, Nicole Estrin, Innovative Health Diagnostics, August 16, 2022 Both laboratories join forces
ORIGINAL ARTICLE, Ritika Dubey, The Hamilton Spectator, July 26, 2022 Q and A: Dr. Harald Stover
Hamilton, ON — On March 23, 2022, nearly 200 people from the region’s thriving life
ORIGINAL ARTICLE – Mohawk College, March 10, 2022 Is your tetanus shot still up to
RAW Podcast The Goodness Wave With Jessica Lunshof – February 16, 2022 LISTEN HERE Hi
Press Release: HyIvy Health Hyivy Health’s innovative pelvic health rehabilitation system looks to provide a
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
As a CAMEDA recipient, Verv Technologies will be collaborating with InertiaPD to advance key aspects of its technology platform.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
With support from the Government of Canada, Innovation Factory launches the Canadian MedTechAlliance (CAMEDA) program.
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.